Delay of 6 weeks between aprotinin injections for tendinopathy reduces risk of allergic reaction

Journal of Science and Medicine in Sport

Volumn 11, Issue 5, 2008, Pages 473-480

  Orchard, John ^a   Massey, Andrew ^b   Rimmer, Janet ^c   Hofman, Jamie ^d   Brown, Richard ^e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

^e Brisbane Orthopaedic and Sports Medicine Centre   (Australia)

Author keywords

Achilles tendon; Allergic reaction; Aprotinin; Patellar tendon; Tendinopathy

Indexed keywords

ADRENALIN; APROTININ; CORTISONE; NITRATE;

ABDOMINAL PAIN; ANAPHYLAXIS; ARTICLE; BLEEDING; BRONCHOSPASM; CONTROLLED STUDY; DIZZINESS; DRUG HYPERSENSITIVITY; ERYTHEMA; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIPULATIVE MEDICINE; NAUSEA; PAIN; PATIENT SATISFACTION; PRURITUS; QUESTIONNAIRE; RASH; SIDE EFFECT; STRETCHING EXERCISE; SWEATING; TENDINITIS; TENDON DISEASE; TENDON SURGERY; THERAPY DELAY; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

ACHILLES TENDON; ADULT; APROTININ; COHORT STUDIES; FEMALE; HEMOSTATICS; HUMANS; HYPERSENSITIVITY; MALE; MEDICAL AUDIT; QUESTIONNAIRES; RISK REDUCTION BEHAVIOR; TENDINOPATHY;

EID: 49849101163     PISSN: 14402440     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsams.2007.05.009     Document Type: Article

References (40)

1. Alfredson H., Pietila T., Jonsson P., and Lorentzon R. Heavy-load eccentric calf-muscle training for the treatment of chronic Achilles tendinosis. Am J Sports Med 26 3 (1998) 360-366
2. Roos E., Engstrom M., Lagerquist A., and Soderberg B. Clinical improvement after 6 weeks of eccentric exercise in patients with mid-portion Achilles tendinopathy-a randomized trial with 1-year follow-up. Scand J Med Sci Sports 14 5 (2004) 286-295
3. Paoloni J., Appleyard R., Nelson J., and Murrell G. Topical glyceryl trinitrate treatment of chronic noninsertional achilles tendinopathy. A randomized, double-blind, placebo-controlled trial. J Bone Joint Surg Am 86A 5 (2004) 916-922
4. Paoloni J., Appleyard R., Nelson J., and Murrell G. Topical nitric oxide application in the treatment of chronic extensor tendinosis at the elbow: a randomized, double-blinded, placebo-controlled clinical trial. Am J Sports Med 31 6 (2003) 915-920
5. Alfredson H., and Ohberg L. Neovascularisation in chronic painful patellar tendinosis-promising results after sclerosing neovessels outside the tendon challenge the need for surgery. Knee Surg Sports Traumatol Arthrosc 13 2 (2005) 74-80
6. van der Windt D., and Koes B. Are corticosteroid injections as effective as physiotherapy for the treatment of a painful shoulder?. In: MacAuley D., and Best T. (Eds). Evidence-based sports medicine (2002), BMJ Books, London 289-317
7. Speed C. Corticosteroid injections in tendon lesions. Br Med J 323 (2001) 382-386
8. Santini A., and Frostick S. How should you treat tennis elbow?. In: MacAuley D., and Best T. (Eds). Evidence-based sports medicine (2002), BMJ Books, London 351-367
9. Bisset L., Beller E., Jull G., Brooks P., Darnell R., and Vincenzino B. Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial. Br Med J 333 (2006) 939
10. Cook J., and Khan K. What is the most appropriate treatment for patellar tendinopathy?. In: MacAuley D., and Best T. (Eds). Evidence-based sports medicine (2002), BMJ Books, London 422-442
11. McLauchlan G, Handoll H. Interventions for treating acute and chronic Achilles tendinitis. The Cochrane Database of Systematic Reviews; 2001 [CD000232].
12. Shrier I., Matheson G., and Kohl H. Achilles tendonitis: are corticosteroid injections useful or harmful?. Clin J Sport Med 6 4 (1996) 218-219
13. Bojanov G., and Belani K. Aprotinin-an update for the perioperative physician. Ann Cardiothorac Anaesth 8 (2005) 75-80
14. Komurcu M., Akkus O., Basbozkurt M., Gur E., and Akkas N. Reduction of restrictive adhesions by local aprotinin application and primary sheath repair in surgically traumatized flexor tendons of the rabbit. J Hand Surg [Am] 22 5 (1997) 826-832
15. Dollery C. Therapeutic drugs (1991), Churchill Livingstone, Edinburgh
16. Chu S., Yang S., Lue K., Hsieh Y., Wu C., and Lu K. Regulation of gelatinases expression by cytokines, endotokin, and pharmacological agents in the human osteoarthritic knee. Connect Tissue Res 45 (2005) 142-150
17. Lee E., Vaughan D., Parikh S., Grodzinsky A., Libby P., Lark M., et al. Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in clutured human vascular smooth muscle cells. Circ Res 78 (1996) 44-49
18. Fu S., Chan B., Wang W., Pau H., Chan K., and Rolf C. Increased expression of matrix metalloproteinase 1 (MMP1) in 11 patients with patellar tendinosis. Acta Orthop Scand 73 6 (2002) 658-662
19. Ireland D., Harrall R., Curry V., Holloway G., Hackney R., Hazleman B., et al. Multiple changes in gene expression in chronic human Achilles tendinopathy. Matrix Biol 20 (2001) 159-169
20. Alfredson H., Lorentzon R., Backman S., Backman A., and Lerner U. cDNA-arrays and real time quantitative PCR techniques in the investigation of chronic human Achilles tendinopathy. J Orthop Res 21 (2003) 970-975
21. Lo I., Marchuk L., Hollinshead R., Hart D., and Frank C. Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase mRNA levels are specifically altered in torn rotator cuff tendons. Am J Sports Med 32 5 (2004) 1223-1229
22. Arnoczky S, Lavagnino M, Egerbacher M, Caballero O, Gardner K. Matrix metalloproteinase inhibitors prevent a decrease in the mechanical properties of stree-deprived tendons. Am J Sports Med; in press. doi:10.1177/0363546506296043.
23. Tumber A., Papaioannou S., Breckon J., Meikle M., Reynolds J., and Hill P. The effects of serine proteinase inhibitors on bone resorption in vitro. J Endocrinol 178 (2003) 437-447
24. Geudj E. La tendinite achilleenne chez jeune sportif. [MD Thesis]; 1973.
25. Genety J., and Pernin E. Utilisation du Zymofren dans le traitment des tendinities chez le sportif. Cah Med Lyon 47 (1971) 135-139
26. Capasso G., Testa V., Maffulli N., and Bifulco G. Aprotinin, corticosteroids and normosaline in the management of patellar tendinopathy in athletes: a prospective randomized study. Sports Exerc Inj 3 (1997) 111-115
27. Maffulli N., Testa V., Capasso G., and Sullo A. Calcific insertional Achilles tendinopathy. Reattachment with bone anchors. Am J Sports Med 32 1 (2004) 174-182
28. Brown R., Orchard J., Kinchington M., Hooper A., and Nalder G. Aprotinin in the management of Achilles tendinopathy: a randomised controlled trial. Br J Sports Med 40 (2006) 275-279
29. Capasso G., Maffulli N., Testa V., and Sgambato A. Preliminary results with peritendinous potease inhibitor injections in the management of Achilles tendinitis. J Sports Traumatol Rel Res 15 (1993) 37-40
30. Aubin F., Javaudin L., and Rochcongar P. Case report of aprotinin in Achilles tendinopathies with athletes (French). J Pharm Clin 16 4 (1997) 270-273
31. Orchard J., Hofman J., and Brown R. The risks of local aprotinin injections for treating chronic tendinopathy. Sport Health 23 3 (2005) 24-28
32. Rochcongar P., Thoribe B., Le Beux P., and Jan J. Tendinopathie calcanéenne et sport: place des injections d'aprotinin. Sci Sports 20 5-6 (2005) 261-267
33. Beierlein W., Scheule A., Dietrich W., and Ziemer G. Forty years of clinical aprotinin use: a review of 124 hypersensitivity reactions. Ann Thorac Surg 79 79 (2005) 741-748
34. Dietrich W., Spath P., Zuhlsdorf M., Dalichau H., Kirchhoff P.G., Kuppe H., et al. Anaphylactic reactions to aprotinin reexposure in cardiac surgery. Anesthesiology 95 (2001) 64-71
35. Shirai T., Shimota H., Chida K., Sano S., Takeuchi Y., and Yasueda H. Anaphylaxis to aprotinin in fibrin sealant. Intern Med 44 10 (2005) 1088-1089
36. Rukin N., and Maffulli N. Systemic allergic reactions to aprotinin injection around the Achilles tendon. J Sci Med Sport 10 (2007) 320-322
37. Tinkelman D., Cole W., and Tunno J. Immunotherapy: a 1-year prospective study to evaluate risk factors of systemic reactions. J Allergy Clin Immunol 95 8-14 (1995)
38. Kay A. Allergy and allergic diseases (1997), Blackwell Science
39. Scheule A., Beierlein W., Arnold S., Eckstein F., Albes J., and Ziemer G. The significance of preformed aprotinin-specific antibodies in cardiosurgical patients. Anesth Analg 90 (2000) 262-266
40. Apeler H., Peters J., Schroder W., Schneider K., Lemm G., Hinz V., et al. Expression, purification, biochemical and pharmacological characterization of a recombinant aprotinin variant. Arzneimittelforschung 54 8 (2004) 483-497